Research
Our mission
In the Mandinova lab we use the epidermis as a model system to study adult stem cells in health and disease. The questions we ask are: How is homeostatic stem cell renewal regulated and how is it balanced with commitment to differentiation to ensure tissue integrity? How does the epidermis withstand and repair frequent injuries and insults? How are genomically damaged stem cells guarded and what permits, in rare cases, aberrant clonal expansion and transformation into benign and malignant lesions? To find our answers, we focus extensively on posttranscriptional regulation of gene expression and its interplay with cellular metabolism. We reason that this approach offers realistic opportunities for therapeutic intervention and identification of “druggable” targets.

Epidermal Stem Cells in
Health and Disease
Our Approach
We combine numerous experimental approaches, including high-resolution imaging, metabolomics, single-cell or pooled RNA-seq, polysome profiling, TRAP-seq and RIP-seq, organoids, flow cytometry and primary cell culture.



Current Projects
Identification of essential early events that govern epidermal stem cells differentiation.
1. Mitochondrial reprogramming during epidermal progenitor commitment to differentiation
2. Protein synthesis drives epidermal stem cell differentiation
RNA-binding proteins in tumor progression
The role of YBX1 in the pathogenesis of keratinocyte-derived cancers
The Y-box binding protein 1 (YBX1), encoded by the YBX1 gene, is a versatile cold-shock protein that interacts with both DNA and RNA to control transcription, RNA processing, and translation. Recently, we have shown that YBX1 is a post-transcriptional regulator essential for maintaining epidermal homeostasis. While YBX1’s significant pro-oncogenic roles in promoting malignant transformation and cell invasion across a wide range of cancers are well documented, its specific mechanisms of action in cutaneous squamous cell carcinoma (cSCC) remain poorly understood. Through the application of multiple ‘omics’ approaches, we aim to elucidate the mechanisms by which YBX1 influences its targets at the post-transcriptional and translational levels.